Drug Sponsors

NeoStem finalizes name change to Caladrius Biosciences

Thursday, June 25, 2015 10:17 AM

Caladrius Biosciences, a cell therapy company with a late-stage clinical program for immuno-oncology, has finalized its corporate name change from NeoStem to Caladrius.

More... »


PrimeGen Biotech opens new research facility, HQ in California

Wednesday, June 24, 2015 10:16 AM

PrimeGen Biotech, a privately-held research firm, has opened a new 10,000 square-foot research facility located in Santa Ana, Calif. Founded by co-founder of AST Computers and former CEO of SRS Labs, Thomas C.K. Yuen plans to utilize PrimeGen's new research facility and his experience in marketing technologies to lead PrimeGen's team of research scientists in the discovery of new breakthroughs in stem cell science, and bringing advanced treatments of degenerative and aging related diseases to market.

More... »


Roche launches a new strategy in Africa

Wednesday, June 24, 2015 09:52 AM

Roche has launched a new Africa Strategy in an effort to expand its footprint in parts of the continent.  

More... »

Sirion Biotech to open new office in Boston

Monday, June 22, 2015 10:30 AM

Sirion Biotech, a viral vector platform company creating viral vector solutions for industry and academic partners headquartered in Germany, has committed to opening a new office in the vicinity of Boston.

More... »

Allergan to acquire Kythera Biopharmaceuticals

Monday, June 22, 2015 10:15 AM

Allergan, a global pharmaceutical company, has agreed to acquire Kythera Biopharmaceuticals, a Westlake Village, Calif.-based biopharmaceutical company, in a cash and equity transaction valued at $75 per Kythera share, or approximately $2.1 billion, subject to the fulfillment of certain customary conditions.

More... »

Biotechnology Industry Organization to become Biotechnology Innovation Organization

Friday, June 19, 2015 12:16 PM

Biotechnology Industry Organization will soon change its name to the Biotechnology Innovation Organization.

More... »

Abbott will vote its Mylan shares in favor of Mylan's proposed acquisition of Perrigo

Wednesday, June 17, 2015 09:51 AM

Abbott has confirmed its continued support for Mylan's growth strategy by stating its intent to vote its 14.5% stake in Mylan in favor of Mylan's proposed acquisition of Perrigo.

More... »

Medivir restructures, partners with GVK BIO

Wednesday, June 17, 2015 09:48 AM

Medivir, a research based pharmaceutical company based in Sweden, has announced a reorganization within its Discovery Research department, increasing its focus within the core areas of oncology and infectious diseases, and a partnership with GVK Biosciences Private (GVK BIO) of Hyderabad in India, designed to deliver enhanced efficiency and quality within its portfolio of research projects while over time reducing overall research costs and enhancing future cost flexibility.

More... »

GSK launches Altius Institute for Biomedical Sciences

Wednesday, June 17, 2015 09:25 AM

GlaxoSmithKline is launching the Altius Institute for Biomedical Sciences, an independent, nonprofit research institute in Seattle. Altius will be pioneering new technologies and approaches for decoding how genes are controlled and how a cell’s “operating system” functions in health and disease. GSK expects to capitalize on rapid progress in understanding gene control to select and validate better drug targets, and to accelerate many key aspects of developing new medicines.

More... »

Roswell Park Cancer Institute spins out new company OmniSeq

Friday, June 12, 2015 12:13 PM

OmniSeq has officially begun its spin out from Roswell Park Cancer Institute (RPCI) and will immediately begin commercializing its suite of innovative products that support a physician-driven, collaborative approach to genomic diagnostics—matching cancer patients to therapies tailored specifically to them. Collectively known as OmniSeq Precision Medicine Technology, OmniSeq provides oncology groups, hospitals and healthcare systems with the first-ever fusion of clinical genomics and a comprehensive information technology solution that provides easy access to actionable insights about their patient’s condition and available treatment options. Like Roswell Park, OmniSeq is based in Buffalo, N.Y.

More... »

CWWeekly

July 6

FDA sued by advocacy groups seeking hepatitis C trials data

Google to test health-tracking wristband to collect clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs